AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $889.25
- 52-wk high
- $996.84
- High
- $897.51
- 52-wk low
- $684.98
- Low
- $880.27
- Prev close
- $889.12
- Mkt cap
- $102.78B
- P/E
- 23.6x
- Volume
- 972.4K
- Fwd P/E
- 19.7x
- Beta
- 0.31
- Div yield
- 0.37%
- P/S
- 0.3x
- P/B
- 5.0x
- Profit margin
- +1.1%
- Op margin
- +1.4%
- ROE
- +0.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 5.2% above what analysts expected.
Earnings per share
$9.44 expected
Revenue
$103.74B expected
GAAP EPS was $5.15 and adjusted EPS was $9.93. The adjusted figure is comparable to consensus.
Reports Nov 4, 2026, in 52 days
EPS expected
$10.53 to $11.26
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $103.15B | $106.16B | $96.30B | $105.38B |
| Cost of what it sold | $99.61B | $102.47B | $92.25B | $101.69B |
| Gross profit | $3.54B | $3.69B | $4.04B | $3.69B |
| What it spent | ||||
| Sales and admin | $2.07B | $2.03B | $1.80B | $2.26B |
| Other operating costs | — | $36.0M | — | $102.0M |
| Total operating expenses | $2.07B | $2.07B | $1.80B | $2.37B |
| What was left | ||||
| Operating profit | $1.47B | $1.62B | $2.25B | $1.32B |
| Interest on debt | $74.0M | $63.0M | $61.0M | $77.0M |
| Profit before tax | $1.40B | $1.63B | $2.13B | $1.31B |
| Tax | $232.0M | $380.0M | $270.0M | $276.0M |
| Net profit | $1.11B | $1.19B | $1.68B | $614.0M |
| EBITDA | $1.66B | $1.84B | $2.26B | $1.39B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
NeutralSep 11McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights
Leans bearishSep 10AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
NeutralSep 10Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
NeutralSep 10ShinyHunters expose 6.4M in attack on medical supplier McKesson
BearishSep 10MasterCraft Boat Holdings SVP Michael O'Connell Reports RSU Vesting and Share Surrender for Tax
Leans bearishSep 9McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
BullishSep 8McKesson at wells fargo healthcare conference: growth, deal push
BullishSep 8
Macro
32 macro signals shaping MCK right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results